To our knowledge, this is the first observation of potassium channel activation-dependent Cav1 dephosphorylation in highly metastatic breast cancer cells, which importantly, may be an effective therapeutic strategy for inhibiting migration and promoting the contact inhibition of metastatic cancers. The gene discussed is CAV1; the disease is breast cancer.